Rare POLR2A Variant Linked to Developmental Regression Shows Response to Low-Dose Dopamine Therapy
A case report describes a girl with a rare POLR2A-related neurodevelopmental disorder who showed regression and improved markedly on low-dose ...
A case report describes a girl with a rare POLR2A-related neurodevelopmental disorder who showed regression and improved markedly on low-dose ...
A single-case report describes a 46-year-old woman with spastic paraplegia type 7 whose FDG PET showed subtle striatal hypometabolism while ...
An exploratory MRI study found widespread blood-brain barrier permeability changes and altered choroid plexus contrast kinetics in patients with Parkinson's ...
A new review maps how chemometric methods paired with spectroscopic, voltammetric, and chromatographic techniques are improving the simultaneous analysis of ...
A qualitative study of 10 people with Parkinson’s disease and nine caregivers found reported symptom improvements alongside practical challenges and ...
Intracranial recordings from 15 people with Parkinson’s disease show that dopamine amplifies delayed subthalamic responses to cortical stimulation while leaving ...
A new review in Frontiers in Nutrition reveals how dietary protein, meal timing, and gut bacteria competitively hijack levodopa transport ...
The FDA has approved tavapadon, branded Juvmo, a once-daily D1 dopamine receptor agonist for Parkinson's disease developed from more than ...
Nine European Parkinson's specialists have issued consensus recommendations for using the newly approved dual-release levodopa formulation IPX203 in patients with ...
An injectable self-healing hydrogel made from an oxidized polysaccharide of the traditional Chinese medicine herb Huangjing protects dopaminergic neurons in ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine